2019年**省!医院出局,医保局要和耗材企业直接结算货款了

2019-10-18 联盟菌 医疗器械经销商联盟

“切断医院和供应商资金往来!医保局统一结算耗材货款,要全国蔓延!”

“切断医院和供应商资金往来!医保局统一结算耗材货款,要全国蔓延!”

医保预付30%,鼓励医保和耗材企业直接结算货款

10月15日,江苏省医保局、财政厅联合发布了《关于省高值医用耗材联盟采购医保支付配套措施的通知》(以下简称《通知》)。

该文件是江苏省医保局、财政厅,就省高值医用耗材联盟采购发布的有关医保支付配套措施。

《通知》要求,江苏各地医保部门,要根据联盟采购中选品种价格、医疗机构与企业约定的采购品种及数量测算联盟采购总金额。医保经办机构应在医保基金总额预算的基础上,按照不低于采购总金额的30%及时预付给医疗机构。医疗机构要按合同约定及时与企业结算货款。鼓励有条件的地区由医保基金与企业直接结算货款。

也就是说,江苏省高值耗材联盟带量采购谈判品种,约定给中标企业的年70%的采购量,医保局要预付30%,而且鼓励各地医保局,测算每年的采购总金额,医保基金与企业直接结算货款!

根据目前圈内流出的《成立江苏省公立医疗机构药品(医用耗材)阳光采购联盟》方案显示,江苏省公立医疗机构药品(医用耗材)阳光采购联盟共计142家三级医院,多家是大三甲!

截止目前,江苏省已经实施两批高值耗材带量采购,首轮55家三级医院,二轮107家二、三医院参加。最终中报企业拿下70%的采购量。

医保预付30%货款,并且鼓励医保和耗材企业直接结算货款,这意味着,整个江苏省将加速实现在耗材购销环节直接踢掉医院,医保统一结算;这也是2019年省级首次提出要医保局统一结算耗材货款!

医保统一结算全国蔓延!切断医院和供应商资金往来

实际上,江苏省文件发布之前,省内市级就已经开始试点。

9月底,南京市药品耗材集中采购平台发布《关于供应(配送)企业开设集中结算银行账户的通知》、《关于供应(配送)企业开设集中结算系统账号、CA的通知》。

明确要求南京全市各定点医药机构的医用耗材及药品收支,须纳入市医药集中采购保障中心设立的专门账户集中结算管理。按照全市统一部署和安排,请各企业对应各自供货的省、市属三级医疗机构结算账户银行,于9月30日前开设医用耗材及药品收支专门账户、办理结算系统专用CA。

也就是说南京市省属这9家医院、市属11家医院药品耗材货款,全部要进行医保统一结算了!

南京先行一步,为江苏省医保统一结算打下坚实的基础。从实施内容来看,已经开始落实到企业设立专项结算账户。

除了南京市,福建省泉州市二级及以上公立医疗机构医用耗材由医保部门统一结算支付已经正式落地了!这也是三明之后,福建省乃至全国第二个实施医保部门统一结算医用耗材货款的城市!

随着福建省医保局接手医用耗材集中采购招标工作,并将医用耗材医保统一结算纳入2019年的工作规划,预计福建全省将也将很快推开!

药品耗材医保统一支付制度源于三明医改,现在又在全国范围内被鼓励推行。意味着医保在采购环节就直接接入限价,在结算环节则踢掉医院,由医保部门向供应商直接结算货款。“谈判降价”也将大为盛行,议价所得用于给医生增加收入,这就是在取消加成、控费、医疗大反腐时期,医院卖力砍价的“兴奋剂”!

推动“一票制”!回扣和虚开发票走向死胡同

医保统一结算货款,从结算环节斩断医院、医保、耗材企业的三角债,一方面在耗材购销领域,推动从源头上解决目前非常严重的回扣和虚开发票问题;

另一方面在很大程度上解决了长期存在的拖欠货款的问题,也减轻了企业的现金流压力。从部分高值耗材开始,“一票制”的落地也将成为可能。

今年7月,云南省人民政府印发《加快推进医疗服务价格调整等改革任务分工的通知》。提出云南全省公立医院效仿阜外医院,实施低值耗材实行“两票制”,探索实施高值耗材”一票制“,直接结算货款。

从全国范围来看,厂家直接配送的“一票制”模式也颇受医疗机构青睐。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1670279, encodeId=4bf316e027985, content=<a href='/topic/show?id=c50be87281c' target=_blank style='color:#2F92EE;'>#结算#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78728, encryptionId=c50be87281c, topicName=结算)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=178c26602075, createdName=vividelife, createdTime=Wed Jul 08 09:50:00 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280538, encodeId=22941280538ef, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Sun Oct 20 05:50:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456284, encodeId=07671456284c8, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Sun Oct 20 05:50:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484383, encodeId=4bd91484383d6, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Sun Oct 20 05:50:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
    2020-07-08 vividelife
  2. [GetPortalCommentsPageByObjectIdResponse(id=1670279, encodeId=4bf316e027985, content=<a href='/topic/show?id=c50be87281c' target=_blank style='color:#2F92EE;'>#结算#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78728, encryptionId=c50be87281c, topicName=结算)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=178c26602075, createdName=vividelife, createdTime=Wed Jul 08 09:50:00 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280538, encodeId=22941280538ef, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Sun Oct 20 05:50:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456284, encodeId=07671456284c8, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Sun Oct 20 05:50:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484383, encodeId=4bd91484383d6, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Sun Oct 20 05:50:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1670279, encodeId=4bf316e027985, content=<a href='/topic/show?id=c50be87281c' target=_blank style='color:#2F92EE;'>#结算#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78728, encryptionId=c50be87281c, topicName=结算)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=178c26602075, createdName=vividelife, createdTime=Wed Jul 08 09:50:00 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280538, encodeId=22941280538ef, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Sun Oct 20 05:50:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456284, encodeId=07671456284c8, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Sun Oct 20 05:50:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484383, encodeId=4bd91484383d6, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Sun Oct 20 05:50:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]
    2019-10-20 hyf030
  4. [GetPortalCommentsPageByObjectIdResponse(id=1670279, encodeId=4bf316e027985, content=<a href='/topic/show?id=c50be87281c' target=_blank style='color:#2F92EE;'>#结算#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78728, encryptionId=c50be87281c, topicName=结算)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=178c26602075, createdName=vividelife, createdTime=Wed Jul 08 09:50:00 CST 2020, time=2020-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280538, encodeId=22941280538ef, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Sun Oct 20 05:50:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1456284, encodeId=07671456284c8, content=<a href='/topic/show?id=3cdb2563088' target=_blank style='color:#2F92EE;'>#企业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25630, encryptionId=3cdb2563088, topicName=企业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a765759005, createdName=hyf030, createdTime=Sun Oct 20 05:50:00 CST 2019, time=2019-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484383, encodeId=4bd91484383d6, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Sun Oct 20 05:50:00 CST 2019, time=2019-10-20, status=1, ipAttribution=)]